Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.

De Sanctis V, Soliman AT, Elsedfy H, Yassin M, Canatan D, Kilinc Y, Sobti P, Skordis N, Karimi M, Raiola G, Galati MC, Bedair E, Fiscina B, El Kholy M; I-CET (International Network on Growth Disorders and Endocrine Complications in Thalassemia).

Pediatr Endocrinol Rev. 2013 Dec;11(2):167-80. Review.

PMID:
24575552
2.

Pathogenesis and management of osteoporosis in thalassemia.

Voskaridou E, Terpos E.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:86-93. Review.

PMID:
19337161
3.

Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.

Skordis N, Toumba M.

Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:300-6. Review.

PMID:
21705982
4.

Low bone mineral density in adolescents with beta-thalassemia.

Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ.

Ann N Y Acad Sci. 2005;1054:462-6.

PMID:
16339698
5.

Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pakbaz Z, Tabatabaie SM, Bouzari N, Pourzahedgilani N, Azarkeivan A, Hashemi SR, Moosavi F, Alebouyeh M, Vosough P, Kimiagar M, Shamshirsaz AA, Moradi M, Habibzadeh MR, Nobakhthaghighi N, Larijani B.

Pediatr Hematol Oncol. 2007 Oct-Nov;24(7):469-79.

PMID:
17786783
6.

Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.

Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD.

Ann Hematol. 2010 Dec;89(12):1207-13. doi: 10.1007/s00277-010-1007-0. Epub 2010 Jun 26.

PMID:
20582415
7.

Gender differences in the prevalence and severity of bone disease in thalassaemia.

Kyriakou A, Savva SC, Savvides I, Pangalou E, Ioannou YS, Christou S, Skordis N.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:116-22.

PMID:
19337164
8.

Endocrine complications in patients with Thalassaemia Major.

Toumba M, Sergis A, Kanaris C, Skordis N.

Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8. Review.

PMID:
18084158
9.

Bone mineral density in adult patients with major thalassaemia: our experience and a brief review of the literature.

Izadyar S, Fazeli M, Izadyar M, Salamati P, Gholamrezanezhad A.

Endokrynol Pol. 2012;63(4):264-9. Review.

10.

Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.

Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A.

Br J Haematol. 2000 Nov;111(2):461-6.

PMID:
11122085
11.

New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.

Voskaridou E, Terpos E.

Br J Haematol. 2004 Oct;127(2):127-39. Review.

PMID:
15461618
12.

Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia.

Vogiatzi MG, Autio KA, Schneider R, Giardina PJ.

J Pediatr Endocrinol Metab. 2004 Oct;17(10):1415-21.

PMID:
15526720
13.

Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites.

Scacchi M, Danesi L, Cattaneo A, Valassi E, Pecori Giraldi F, Argento C, D'Angelo E, Mirra N, Carnelli V, Zanaboni L, Tampieri B, Cappellini MD, Cavagnini F.

Clin Endocrinol (Oxf). 2008 Aug;69(2):202-7. doi: 10.1111/j.1365-2265.2008.03191.x. Epub 2008 Jan 21.

PMID:
18221395
14.

Osteoporosis prevention, diagnosis, and therapy.

[No authors listed]

NIH Consens Statement. 2000 Mar 27-29;17(1):1-45. Review.

PMID:
11525451
15.

High prevalence of low bone mass in thalassaemia major.

Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B.

Br J Haematol. 1998 Dec;103(4):911-5.

PMID:
9886300
16.

Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major.

Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M.

Hormones (Athens). 2007 Oct-Dec;6(4):334-40.

17.

Bone disease and skeletal complications in patients with β thalassemia major.

Haidar R, Musallam KM, Taher AT.

Bone. 2011 Mar 1;48(3):425-32. doi: 10.1016/j.bone.2010.10.173. Epub 2010 Oct 28. Review.

PMID:
21035575
18.

The morbidity of bone disease in thalassemia.

Vichinsky EP.

Ann N Y Acad Sci. 1998 Jun 30;850:344-8. Review.

PMID:
9668556
19.

Treatment options for thalassemia patients with osteoporosis.

Terpos E, Voskaridou E.

Ann N Y Acad Sci. 2010 Aug;1202:237-43. doi: 10.1111/j.1749-6632.2010.05542.x.

PMID:
20712799
20.

The spine in β-thalassemia syndromes.

Haidar R, Mhaidli H, Musallam KM, Taher AT.

Spine (Phila Pa 1976). 2012 Feb 15;37(4):334-9. doi: 10.1097/BRS.0b013e31821bd095. Review.

PMID:
21494197
Items per page

Supplemental Content

Write to the Help Desk